Kids are overdosing on med meant to fight opioid addiction

June 25, 2018 by Alan Mozes, Healthday Reporter

(HealthDay)—Young American children are being sickened—and even dying—after being poisoned by a drug used to fight opioid addiction, a new report contends.

Investigators reported that between 2007 and 2016, more than 11,000 emergency calls were made to U.S. poison control centers after a child or teen was exposed to , a powerful prescription medication that helps wean people off opioids.

The vast majority of calls (86 percent) involved under the age of 6, and nearly all of those cases resulted from accidental exposure. Eleven of the children died, according to the report.

Not all cases were purely accidental, however. Among those aged 13 to 19, three-quarters of the calls involved intentional usage of the drug, resulting in four deaths, the researchers said.

"Although buprenorphine is important for the treatment of use disorder, pediatric exposure to this medication can result in serious adverse outcomes," said study author Dr. Gary Smith. The medication can cause extreme drowsiness and/or vomiting when taken improperly, he explained.

What's more, Smith suggested that the scale of the problem may be larger than the current numbers suggest, given that "not all pediatric buprenorphine exposures are reported to poison control centers."

The upshot, he said, is that "safe storage of all opioids, including buprenorphine, is crucial. Parents and caregivers who take buprenorphine need to store it safely: up, away, and out of sight. In a locked cabinet is best."

Health care providers could help, Smith said, by proactively discussing the issue and best-practice safety protocols with parents and caregivers of .

And teens, Smith added, should be counseled on the risks involved when it comes to misusing drugs of this kind.

Smith is a professor of pediatrics, emergency medicine and epidemiology at Ohio State University, and director of the Center for Injury Research and Policy at Nationwide Children's Hospital in Columbus, Ohio.

He and his colleagues published their findings online June 25 in the journal Pediatrics.

The rise in pediatric poisonings coincides with the engulfing the United States. Between 2001 and 2016, the number of opioid-related deaths more than quadrupled. By 2016, one in 65 deaths nationwide was linked to an opioid overdose—whether from an like OxyContin or an illegal drug such as heroin.

The study authors said that between 2005 and 2010, the annual number of patients who received a buprenorphine prescription rocketed up from 100,000 to more than 800,000.

The new study analyzed information covering 2007 through 2016 from the National Poison Data System.

Among poison center calls involving young children, 45 percent ended up with the child being taken to a health care center, and about one-fifth of the calls ultimately turned out to be serious medical situations.

For teens, a little more than one-fifth wound up being admitted to a hospital, and roughly the same percentage were serious cases. About one-quarter of the teens had been using other substances in addition to buprenorphine. And 150 cases were believed to be the result of a suicide attempt, the study authors said.

Besides safe storage and counseling, another way to reduce risk might be to change the way buprenorphine is packaged, Smith suggested.

"Drug manufacturers should use unit-dose packaging—often called blister packs—for all buprenorphine products to help prevent unintentional access and exposure by young children," he said.

That thought was seconded by Dr. George Sam Wang, an assistant professor of pediatrics with the University of Colorado, and a pediatric emergency doctor at Children's Hospital Colorado.

"We have previously shown that unit-dose packaging—a form of child-resistant packaging—can decrease pediatric exposures to buprenorphine-naloxone products," Wang said. He was part of a team that recently reported that switching to single-dose packaging led a 79 percent decrease in the number of unintentional exposures among children under 6 years of age.

D. Christopher Garrett is senior media advisor with the U.S. Substance Abuse and Mental Health Services Administration's (SAMHSA) office of communications. He said it's important to take steps to safeguard children, while stressing the need to continue encouraging those struggling with opioid addiction to get the best opioid treatment available.

"SAMHSA hopes all parents and guardians would exercise caution to prevent their children from being able to access all medication. Proper storage and disposal of all medications are essential to prevent harmful exposure to children," Garrett said.

"We continue to work through funding and training, however, to expand access to medication-assisted treatment (MAT) that incorporates such Food and Drug Administration-approved medications as buprenorphine," he added. "We know MAT is the scientifically proven standard for helping people who have opioid use disorders to recover and to resume productive lives."

Garrett said anyone seeking help should contact SAMHSA's National Helpline at 1-800-662-HELP (4357).

Explore further: Unit-dose packaging cuts accidental peds opioid exposures

More information: Gary A. Smith, M.D., Dr.PH., professor of pediatrics, emergency medicine and epidemiology, Ohio State University, and director, Center for Injury Research and Policy, Nationwide Children's Hospital, Columbus, Ohio; George Sam Wang, M.D., FAAP, assistant professor, pediatrics, University of Colorado, and pediatric emergency doctor, Children's Hospital Colorado; D. Christopher Garrett, senior media advisor, office of communications, U.S. Substance Abuse and Mental Health Services Administration, Washington, D.C.; June 25, 2018, Pediatrics, online

There's more on buprenorphine at the U.S. Substance Abuse and Mental Health Services Administration.

Related Stories

Unit-dose packaging cuts accidental peds opioid exposures

May 3, 2018
(HealthDay)—The transition to use of buprenorphine products with unit-dose packaging (UDP) starting in 2010 correlated with a reduction in unintentional pediatric exposures to buprenorphine-naloxone, according to a study ...

Simple drug packaging change could save toddlers' lives

May 3, 2018
(HealthDay)—As America's opioid crisis continues, too many toddlers are accidentally overdosing on narcotic medicines. But a new study suggests that better packaging might curb the problem.

Poison centers receive 32 calls a day about kids exposed to prescription opioids

March 20, 2017
A new study published online today by Pediatrics and conducted by the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children's Hospital found that there were more than 188,000 calls ...

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

US poison control centers receive 29 calls per day about children exposed to ADHD medications

May 21, 2018
A new study conducted by the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children's Hospital found that there were more than 156,000 calls to US Poison Control Centers regarding ...

Methadone and buprenorphine decrease mortality after nonfatal overdose

June 19, 2018
A new study out of Boston Medical Center's Grayken Center for Addiction on opioid overdose survivors indicates that two FDA approved medications to treat opioid use disorder save lives, but only three out of 10 overdose survivors ...

Recommended for you

Fatty acids can slow down an overheated immune system

September 21, 2018
Sometimes, the immune system mistakenly attacks the body's healthy tissue by responding to infections that do not exist. This causes chronic inflammation and leads to diseases including lupus (SLE), and this is what happens ...

Patient-centered visual aid helps physicians discuss risks, treatments with parents

September 21, 2018
A series of illustrations and charts designed as decision aids for parents of children with minor head injuries helped them communicate with emergency medicine physicians and make informed decisions about their child's care, ...

Study shows surprise low-level ozone impact on asthma patients

September 21, 2018
A new study led by UNC School of Medicine researchers indicates that ozone has a greater impact on asthma patients than previously thought. The study, published in the Journal of Allergy and Clinical Immunology, recruited ...

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Fish-rich diets may boost babies' brain development

September 20, 2018
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy. This is the suggestion from a small-scale study led by Kirsi Laitinen of the University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.